EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Utilisation of molecularly imprinting technology for the detection of glucocorticoids for a point of care surface plasmon resonance (SPR) device

Chester Blackburn, Mark V Sullivan, Molly I Wild, Abbie J O' Connor, Nicholas W Turner

Analytica Chimica Acta · 2024-01 · 1285 · 342004

DOI: 10.1016/j.aca.2023.342004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytica Chimica Acta, 2024-01. Verfasst von Chester Blackburn und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Sheffield, Dainton Building, 13 Brook Hill, Sheffield, S3 7HF, UK. Hauptthemen laut MEDLINE: Surface Plasmon Resonance, Molecular Imprinting. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Engineering and Physical Sciences Research Council, University of Sheffield.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Herein, we describe the synthesis and characterisation of four synthetic recognition materials (nanoMIPs) selective for the glucocorticoid steroids - prednisolone, prednisone, dexamethasone, and cortisone. Using a solid-phase synthesis approach, these materials were then applied in the development of a surface plasmon resonance (SPR) sensor for the detection of these four targets in doped urine, to mimic the routine testing of agricultural waste for possible environmental exposure. The synthesised particles displayed a range of sizes between 104 and 160 nm. Affinity studies were performed, and these synthetic materials were shown to display nanomolar affinities (15.9-62.8 nM) towards their desired targets. Furthermore, we conducted cross-reactivity studies to assess the materials selectivity towards their desired target and the materials showed excellent selectivity when compared to the non-desired target, with selectivity factors calculated. Furthermore, through the use of 3D visualisation it can be seen that small changes between structures (such as a hydroxyl to ketone transformation) there is excellent selectivity between the compounds in the ranges of 100 fold plus. Using Surine™ doped samples the materials offered comparable nanomolar affinities (10.7-75.7 nM) towards their targets when compared to the standardised buffer preparation. Detection levels in urine for all compounds was in the nanomolar range. The developed sensor offers potential for these devices to be used in the prevention of these pharmaceutical compounds to enter the surrounding environment through agricultural waste through monitoring at source. Likewise, they can be used to monitor use in clinical samples.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Surface Plasmon ResonanceMolecular ImprintingGlucocorticoidsPoint-of-Care SystemsTechnology

Substanzen

Glucocorticoids

Autor:innen und Institutionen

  • Department of Chemistry, University of Sheffield, Dainton Building, 13 Brook Hill, Sheffield, S3 7HF, UK.
  • Department of Chemistry, University of Sheffield, Dainton Building, 13 Brook Hill, Sheffield, S3 7HF, UK. Electronic address: n.w.turner@sheffield.ac.uk.

Förderung

  • Engineering and Physical Sciences Research Council
  • University of Sheffield

Zitieren

APA

Blackburn, C., Sullivan, M. V., Wild, M. I., O' Connor, A. J., & Turner, N. W. (2024). Utilisation of molecularly imprinting technology for the detection of glucocorticoids for a point of care surface plasmon resonance (SPR) device. Analytica Chimica Acta, 1285, 342004. https://doi.org/10.1016/j.aca.2023.342004

Vancouver

Blackburn C, Sullivan MV, Wild MI, O' Connor AJ, Turner NW. Utilisation of molecularly imprinting technology for the detection of glucocorticoids for a point of care surface plasmon resonance (SPR) device. Analytica Chimica Acta. 2024;1285:342004. doi:10.1016/j.aca.2023.342004

BibTeX
@article{Blackburn2024,
  author = {Blackburn, Chester and Sullivan, Mark V and Wild, Molly I and O' Connor, Abbie J and Turner, Nicholas W},
  title = {Utilisation of molecularly imprinting technology for the detection of glucocorticoids for a point of care surface plasmon resonance (SPR) device},
  journal = {Analytica Chimica Acta},
  year = {2024},
  volume = {1285},
  pages = {342004},
  doi = {10.1016/j.aca.2023.342004}
}
Kostenlos starten →